News | December 02, 2021
Amrutanjan Health Care opens first store in Chennai
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
Caspian Debt has in principle committed up to Rs 35 crores to SAMRIDH’s commercial debt investment pool
The drug is indicated for mild and transient episodes of heart block
The company has posted net profit / (loss) of Rs.5.33 crores for the 12 months period ended March 31, 2021
The NDA submission follows the successful completion of a pivotal Phase III global clinical trial
This milestone marks the first-ever NDA submission to the U.S. FDA for a drug, fully discovered and developed by an Indian pharmaceutical company
Reinforcing commitment to ethical and sustainable growth
Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
Subscribe To Our Newsletter & Stay Updated
